pembrolizumab monotherapy for older/abvd-ineligible patients with hodgkin lymphoma
Published 1 year ago • 348 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
1:58
outcomes of patients with hodgkin lymphoma undergoing allohsct after pembrolizumab therapy
-
2:57
favezelimab plus pembrolizumab in transplant-ineligible patients with r/r classical hodgkin lymphoma
-
1:28
concurrent pembrolizumab and chemotherapy in classical hodgkin lymphoma
-
1:43
keynote-667: pembrolizumab for children and young adults with classical hodgkin lymphoma
-
0:49
pembrolizumab combined with favezelimab for heavily pretreated classical hodgkin lymphoma
-
3:03
how bad is lymphoma cancer?
-
9:25
mgus diagnosis: a step-by-step approach
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
1:39
pembrolizumab & ice for hodgkin lymphoma
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
1:10
avenue: avelumab for classical hodgkin lymphoma
-
1:36
possibilities for the use of pembrolizumab in lymphoma treatment
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
1:59
updates on the use of nivolumab in hodgkin lymphoma & how this agent may impact treatment
-
3:07
keynote-204 in r/r classical hodgkin lymphoma
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:19
gemcitabine and bendamustine as a salvage regimen for recurrent/refractory hodgkin lymphoma
-
1:57
the current hodgkin lymphoma immunotherapy landscape
-
1:12
optimizing treatment in hodgkin lymphoma